The Greater Cannabis Company, Inc. (GCAN)
GCAN Stock Price Chart
Explore The Greater Cannabis Company, Inc. interactive price chart. Choose custom timeframes to analyze GCAN price movements and trends.
GCAN Company Profile
Discover essential business fundamentals and corporate details for The Greater Cannabis Company, Inc. (GCAN) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
18 Sept 2018
Employees
1.00
Website
https://www.gcanrx.comCEO
Aitan Zacharin
Description
The Greater Cannabis Company, Inc. engages in the development and commercialization of cannabinoid therapeutics. It offers an oral transmucosal patch platform, which provides loaded actives absorbed by the buccal mucosa into the body. The company was founded in 2014 and is based in Baltimore, Maryland.
GCAN Financial Timeline
Browse a chronological timeline of The Greater Cannabis Company, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Earnings released on 30 Sept 2023
EPS came in at -$0.00 .
Earnings released on 30 Jun 2023
EPS came in at -$0.00 .
Earnings released on 31 Mar 2023
EPS came in at -$0.00 .
GCAN Stock Performance
Access detailed GCAN performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.